The developments at Holland Capital in 2024 reflect our strong ambitions
Amsterdam/ Düsseldorf, 30th of December 2024 –The developments at Holland Capital in 2024 reflect our strong ambitions. Guided by a focused investment strategy, we continued to actively engage in the high-growth markets of Technology, Healthcare, and Agrifood. Reflecting on a successful year, we completed several key transactions and further strengthened our team.
2024 achievements
- The launch of our fund, Holland Capital Growth and Buy-Out Fund V
- Number of deals in the Netherlands: 5
- Number of add-on acquisitions in the Netherlands: 13
- Number of add-on acquisitions in Germany: 2
- Number of exits: 2
- Number of new colleagues: 4
Sector focus and an entrepreneurial hands-on approach: With specialized sector teams, we focus on the sectors of Healthcare, Technology, and Agrifood, both within the Growth & Buy-out and Venture & Growth segments. We understand the dynamics and opportunities in these sectors and have an extensive network. Holland Capital is not a passive investor; we work closely with management to define and execute strategies. Where needed, our operational team also contributes hands-on to the realization of specific projects within the company.
Which companies would we like to connect with?
- Sector: Technology, Healthcare, and Agrifood
- Positive outlook: Significant growth potential, both autonomous and buy-and-build
- Growth & Buy-out:
- Healthy profitability: cash flow from operations (EBITDA) between EUR 1 – 10m
- Smaller companies: considered as add-on acquisitions for our existing portfolio companies
- Larger companies: considered together with a co-investor
- Venture & Growth:
- Start-ups and scale-ups: EBITDA EUR <1m
- Cash flow negative (in an accelerated growth scenario)
- Revenue EUR 0 – 5m
What to expect from us?
- Flexible approach to transaction structures: We strive to adapt each structure to the needs of the company and its shareholders. Depending on the type of investment, Holland Capital either provides growth capital and/or acquires existing shares. We are flexible regarding the final capital structure: both majority and minority stakes are possible.
- Deal certainty and an efficient process: Thanks to our sector expertise, we are able to quickly assess a business model and put a fair price on the table. Since the partnership with the entrepreneur and/or the management team is the cornerstone of our investment, we devote above-average attention to ensuring the process is completed efficiently, in the right spirit, and with mutual respect for both parties.
- Transparency towards advisors: We appreciate it when advisors involve us early in discussions with entrepreneurs and/or management teams. In such cases, we always ensure that the advisor’s interests are well safeguarded throughout the process. The advisor retains the flexibility to decide whether to represent the sell-side or buy-side in a potential transaction.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare, Technology, and Agrifood-Tech sector.
Holland Venture wins M&A ‘Best Small Cap Deal’ award
Amsterdam, 14 December 2018 - Yesterday the annual ceremony of the M & A awards took place in the Beurs van Berlage in Amsterdam. Holland Venture was nominated for two awards: 'Best Venture & Growth Capital Provider' and 'Best Small Cap Deal'. Holland...
Holland Venture wint M&A ‘Best Small Cap Deal’ award
Amsterdam, 14 december 2018 - Gister vond de jaarlijkse uitreiking van de M&A awards plaats in de Beurs van Berlage in Amsterdam. Holland Venture ging naar de uitreiking met twee nominaties op zak. Te weten ‘Best Venture & Growth Capital Provider’ en ‘Best...
Holland Venture invests in Mobile Accessories company Telco Accessories B.V.
Amsterdam, 12 December 2017 – Together with the management, Investment company Holland Venture invests in the internationally active Mobile Accessories provider Telco Accessories B.V. The investment allows Telco to realise her growth ambitions by means of both organic...
Highcare supports management buy-out Zorgzuster
Roosendaal/Maastricht, 27 November 2018 – Highcare and Ralph Smeets acquire all shares of Zorgzuster Nederland from Start People (part of USG People The Netherlands). Ralph Smeets has founded Zorgzuster in 2010. Highcare is the employment and deployment agency in the...
Highcare ondersteunt management buy-out zorgzuster
Roosendaal/Maastricht, 27 november 2018 - Highcare en Ralph Smeets, nemen alle aandelen in Zorgzuster Nederland over van Start People (onderdeel van USG People The Netherlands). Ralph Smeets heeft in 2010 Zorgzuster opgericht. Highcare is het uitzend- en...
Holland Venture invests in WSO2 integrator Yenlo
Amsterdam, 19 November 2018 – Private Equity firm Holland Venture invests in Yenlo, the leading integration specialist on WSO2 open source middleware technology. The management and shareholders have set a target for the coming years to strengthen the growth of the...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl